Federal Contractor Profile
Dynport Vaccine Company LLC
$216M obligated·36 awards·2 agencies·6 NAICS
Federal Contracts
Showing award actions 51–100 of 170 funded award actions, most recent first.
- Contracts with positive obligations
- 36
- Funded award actions shown
- 170
- Obligations shown
- $216M
- Awarding agencies
- 2
This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.
Award data as of August 5, 2026. Source: USAspending federal award records.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| May 13, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93021F00202 | 541711 | PHASE 1 | $797K |
| Mar 23, 2021 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | 0002 | 541712 | IGF::OT::IGF - RESEARCH&DEVELOPMENT IN SUPPORT OF THE US ARMY MEDICAL MATERIEL DEVELOPMENT ACTIVITY (USAMMDA) FOR THE PERFORMANCE OF A PHASE I, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE LONG-TERM OPHTHALMIC SAFETY OF TAFENOQUINE VERSUS PLACEBO. | $867K |
| Mar 10, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93020F00001 | 541711 | 1500005I DYNPORT VACCINE COMPANY | $9K |
| Dec 16, 2020 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | 0002 | 541712 | IGF::OT::IGF - RESEARCH&DEVELOPMENT IN SUPPORT OF THE US ARMY MEDICAL MATERIEL DEVELOPMENT ACTIVITY (USAMMDA) FOR THE PERFORMANCE OF A PHASE I, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE LONG-TERM OPHTHALMIC SAFETY OF TAFENOQUINE VERSUS PLACEBO. | $1.3M |
| Dec 15, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93021F00001 | 541711 | PHASE 1 | $136K |
| Dec 9, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200003 | 541711 | IGF::OT::IGF 1500005I DYNPORT VACCINE COMPANY, LLC; TO 15-0109.B1.0052--05 BASE; BIOD CAN 8470038; $59,564 | $3K |
| Apr 9, 2020 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $2.2M |
| Mar 9, 2020 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $3.3M |
| Feb 26, 2020 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | 0002 | 541712 | IGF::OT::IGF - RESEARCH&DEVELOPMENT IN SUPPORT OF THE US ARMY MEDICAL MATERIEL DEVELOPMENT ACTIVITY (USAMMDA) FOR THE PERFORMANCE OF A PHASE I, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE LONG-TERM OPHTHALMIC SAFETY OF TAFENOQUINE VERSUS PLACEBO. | $2.2M |
| Feb 5, 2020 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $30M |
| Dec 18, 2019 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $6.0M |
| Dec 15, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93020F00001 | 541711 | 1500005I DYNPORT VACCINE COMPANY | $121K |
| Nov 7, 2019 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $12M |
| Sep 30, 2019 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $199K |
| Jul 15, 2019 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $1.1M |
| Apr 16, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200006 | 541711 | IGF::OT::IGF 1500005I DYNPORT VACCINE COMPANY, LLC; PHASE 1 CLINICAL TRIALS UNITS FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES; TO 16-0110.B1.0066--05 BASE TASK ORDER FUNDING; CARB CAN 8023349; | $20K |
| Apr 4, 2019 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0056 | 541711 | PROGRAM REPORTING - TECHNICAL | $11M |
| Jan 10, 2019 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | 0002 | 541712 | IGF::OT::IGF - RESEARCH&DEVELOPMENT IN SUPPORT OF THE US ARMY MEDICAL MATERIEL DEVELOPMENT ACTIVITY (USAMMDA) FOR THE PERFORMANCE OF A PHASE I, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE LONG-TERM OPHTHALMIC SAFETY OF TAFENOQUINE VERSUS PLACEBO. | $4.6M |
| Dec 14, 2018 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00125 | 541711 | 1500005I DYNPORT VACCINE COMPANY, LLC; TO FY.2019.A1.0118--05 BASE TASK ORDER FUNDING; BIOD CAN 8470038 $117,283 | $117K |
| Nov 20, 2018 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH18F0066 | 541712 | MARKET RESEARCH FOR MARKET ANALYSIS FOR SEVERE HEMORRHAGE CONTROL (EXTREMITY, JUNCTIONAL AND TRUNCAL) | $226K |
| Sep 21, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0056 | 541711 | PROGRAM REPORTING - TECHNICAL | $4.4M |
| Aug 30, 2018 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | 0002 | 541712 | IGF::OT::IGF - RESEARCH&DEVELOPMENT IN SUPPORT OF THE US ARMY MEDICAL MATERIEL DEVELOPMENT ACTIVITY (USAMMDA) FOR THE PERFORMANCE OF A PHASE I, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE LONG-TERM OPHTHALMIC SAFETY OF TAFENOQUINE VERSUS PLACEBO. | $2.3M |
| Jul 26, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0056 | 541711 | PROGRAM REPORTING - TECHNICAL | $638K |
| Jul 3, 2018 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | 0002 | 541712 | IGF::OT::IGF - RESEARCH&DEVELOPMENT IN SUPPORT OF THE US ARMY MEDICAL MATERIEL DEVELOPMENT ACTIVITY (USAMMDA) FOR THE PERFORMANCE OF A PHASE I, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE LONG-TERM OPHTHALMIC SAFETY OF TAFENOQUINE VERSUS PLACEBO. | $2.6M |
| Jun 26, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0056 | 541711 | PROGRAM REPORTING - TECHNICAL | $7K |
| Jun 5, 2018 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200003 | 541711 | IGF::OT::IGF 1500005I DYNPORT VACCINE COMPANY, LLC; TO 15-0109.B1.0052--05 BASE; BIOD CAN 8470038; $59,564 | $184K |
| May 18, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0056 | 541711 | PROGRAM REPORTING - TECHNICAL | $1.5M |
| Mar 19, 2018 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH18F0066 | 541712 | MARKET RESEARCH FOR MARKET ANALYSIS FOR SEVERE HEMORRHAGE CONTROL (EXTREMITY, JUNCTIONAL AND TRUNCAL) | $377K |
| Feb 16, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0056 | 541711 | PROGRAM REPORTING - TECHNICAL | $2.0M |
| Feb 13, 2018 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $970K |
| Jan 25, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0056 | 541711 | PROGRAM REPORTING - TECHNICAL | $500K |
| Jan 3, 2018 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $878K |
| Dec 20, 2017 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0056 | 541711 | PROGRAM REPORTING - TECHNICAL | $5.0M |
| Dec 15, 2017 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200007 | 541711 | 1500005I DYNPORT VACCINE COMPANY, LLC; TO FY.2018.A1.0095--05 BASE TASK ORDER FUNDING; CAN 8470038 $107,814 | $108K |
| Dec 12, 2017 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | 0001 | 541712 | IGF::OT::IGF CPP PHASE 2 CLINICAL TRIAL | $500K |
| Dec 11, 2017 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | 0002 | 541712 | IGF::OT::IGF - RESEARCH&DEVELOPMENT IN SUPPORT OF THE US ARMY MEDICAL MATERIEL DEVELOPMENT ACTIVITY (USAMMDA) FOR THE PERFORMANCE OF A PHASE I, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE LONG-TERM OPHTHALMIC SAFETY OF TAFENOQUINE VERSUS PLACEBO. | $2.0M |
| Oct 27, 2017 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0056 | 541711 | PROGRAM REPORTING - TECHNICAL | $4.8M |
| Oct 26, 2017 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $12M |
| Sep 28, 2017 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0056 | 541711 | PROGRAM REPORTING - TECHNICAL | $3.0M |
| Sep 27, 2017 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $2.9M |
| Sep 27, 2017 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $593K |
| Sep 26, 2017 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $5.3M |
| Sep 26, 2017 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $2.7M |
| Sep 12, 2017 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0056 | 541711 | PROGRAM REPORTING - TECHNICAL | $2.7M |
| Sep 9, 2017 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | 0002 | 541712 | IGF::OT::IGF - RESEARCH&DEVELOPMENT IN SUPPORT OF THE US ARMY MEDICAL MATERIEL DEVELOPMENT ACTIVITY (USAMMDA) FOR THE PERFORMANCE OF A PHASE I, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE LONG-TERM OPHTHALMIC SAFETY OF TAFENOQUINE VERSUS PLACEBO. | $2.0M |
| Sep 1, 2017 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $350K |
| Aug 23, 2017 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $55K |
| Aug 17, 2017 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $3.0M |
| Aug 14, 2017 | Department of DefenseW6QK ACC-APG NATICK | DAMD1798C8024 | — | 199802!2100!1273!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1798C8024 !A!*!* !19971106!19971130!958462681!927921627!003242013!N!03543!DYNTEL CORP !2000 EDMUND HALLEY DR !RESTON !VA!20191!66672!059!51!RESTON !FAIRFAX !VIRGINIA !0001!+000019021453!N!N!000000000000!AN13!RDTE/BIOMEDICAL - ADV TECH DEV !C9B!MEDICAL & DENTAL SUPPLIES & EQ!1000!NOT DISCERNABLE OR CLASSIFIED !2836!3!*!*!*!B!B!*!A !U!R!2!004!C!* !C!N!Z!* !* !N!C!*!A!Z!A!A!A!*!* !*!N!A!C!N!*!*!*!*!*! | $859K |
| Aug 9, 2017 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | 0002 | 541712 | IGF::OT::IGF - RESEARCH&DEVELOPMENT IN SUPPORT OF THE US ARMY MEDICAL MATERIEL DEVELOPMENT ACTIVITY (USAMMDA) FOR THE PERFORMANCE OF A PHASE I, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE LONG-TERM OPHTHALMIC SAFETY OF TAFENOQUINE VERSUS PLACEBO. | $1.2M |
Get Alerted Before Dynport Vaccine Company LLC's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start for free